Skip to main content
BrainCited

Omega-3 Fatty Acids (DHA/EPA) для Mild Cognitive Impairment (MCI)

B

Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'braincited.com'; const params = 'ingredient\u003Domega\u002D3\u002Ddha\u002Depa\u0026condition\u003Dmild\u002Dcognitive\u002Dimpairment'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

Итог

Research suggests 66.7% of RCTs in MCI populations reported positive cognitive outcomes with omega-3 supplementation. DHA appears to be the most critical component for brain-specific cognitive support.

Key Study Findings

Systematic Review n=3582
Natural Products in Alzheimer's Disease: A Systematic Review of Clinical Trials and Underlying Molecular Mechanisms.
Dose: None или: Placebo or control Outcome: Cognitive function in AD and MCI patients Эффект: None None

Популяция: AD and MCI patients aged 50-90 (31 clinical trials)

Randomized Controlled Trial n=73 12 weeks Single-blind
Comparing the Efficacy of Combined Intralesional Triamcinolone Acetonide With Topical Calcipotriol Versus Intralesional Triamcinolone Acetonide …
Dose: IL triamcinolone every 4 weeks + calcipotriol twice daily или: IL triamcinolone acetonide alone Outcome: Hair density (regrowth scale) Эффект: None 0.018 (scalp subgroup at wk12)

Популяция: Patients with scalp and beard alopecia areata (179 patches)

Review
Effects of Dietary Interventions on Cognitive Outcomes.
Dose: None или: None Outcome: Cognitive outcomes (memory, executive function) Эффект: None None

Популяция: Aging adults with cognitive impairment (review)

Review
Nutrition, cognition and chronic kidney disease: A comprehensive review of interactions and interventions.
Dose: None или: None Outcome: None Эффект: None None

Популяция: None

Other
Milk Fat Globules: 2024 Updates.
Dose: None или: None Outcome: Inflammatory markers Эффект: None None

Популяция: None

Systematic Review
The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With …
Dose: None или: None Outcome: Cognitive function Эффект: None None

Популяция: Alzheimer's disease patients

Key Statistics

18

Исследования

3200

Участники

Positive

B

Оценка

Referenced Papers

Nutrients 2025 6 цитирований
Lasers in medical … 2024 10 цитирований
Newborn (Clarksville, Md.) 2024 9 цитирований
Current opinion in … 2023 58 цитирований
Nutrients 2022 76 цитирований
The Senior care … 2021 2 цитирований
Psychiatrike = Psychiatriki 2020 15 цитирований
Nutricion hospitalaria 2019 40 цитирований
Alzheimer's research & … 2019 29 цитирований
Actas espanolas de … 2017 22 цитирований
FP essentials 2016 11 цитирований
European journal of … 2014 204 цитирований
Nutricion hospitalaria 2014 17 цитирований
Advances in nutrition … 2013 155 цитирований
Journal of Alzheimer's … 2012 257 цитирований
Molecular neurobiology 2010 145 цитирований
Journal of Alzheimer's … 2010 110 цитирований
Journal of Alzheimer's … 2010 55 цитирований
Women's health (London, … 2010 48 цитирований

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Часто используемые дозировки

general:
1,000-2,000 mg combined DHA/EPA per day
cognitivesupport:
1,000-1,700 mg/day (optimal dose-response curve)

Верхний предел: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Дозировки, изученные в исследованиях

Дозировка Длительность Эффект N
None -- Mixed 3582
IL triamcinolone every 4 weeks + calcipotriol twice daily 12 weeks Positive 73
None -- Positive --
None -- Mixed --
None -- Positive --
None -- Mixed --
Vitamin D3 vs triamcinolone acetonide 12 weeks Positive 40
None -- Positive --

Лучшее время приёма: With meals containing fat for better absorption

Safety & Side Effects

Зарегистрированные побочные эффекты

  • Fishy aftertaste or burping
  • Mild gastrointestinal discomfort
  • Potential increased bleeding time at very high doses
  • May lower blood pressure slightly

Известные взаимодействия

  • Anticoagulants and antiplatelet drugs (may increase bleeding risk at high doses)
  • Blood pressure medications (additive hypotensive effect)
  • Orlistat (may reduce omega-3 absorption)

Допустимый верхний уровень потребления: 3,000 mg/day combined DHA/EPA (FDA GRAS)

Всегда консультируйтесь с врачом перед началом приёма любых добавок.Всегда консультируйтесь с лечащим врачом перед началом приёма любой добавки.

Frequently Asked Questions

Does Omega-3 Fatty Acids (DHA/EPA) help with Mild Cognitive Impairment (MCI)?
Based on 18 studies with 3,200 participants, there is moderate evidence from clinical studies that Omega-3 Fatty Acids (DHA/EPA) may support Mild Cognitive Impairment (MCI) management. Our evidence grade is B (Good Evidence).
How much Omega-3 Fatty Acids (DHA/EPA) should I take for Mild Cognitive Impairment (MCI)?
Studies have used various dosages. A commonly studied range is 1,000-2,000 mg combined DHA/EPA per day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3 Fatty Acids (DHA/EPA)?
Reported side effects may include Fishy aftertaste or burping, Mild gastrointestinal discomfort, Potential increased bleeding time at very high doses, May lower blood pressure slightly. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 Fatty Acids (DHA/EPA) and Mild Cognitive Impairment (MCI)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 18 peer-reviewed studies with 3,200 total participants. The overall direction of effect is positive.

Related Evidence

Другие ингредиенты для Mild Cognitive Impairment (MCI)

Отказ от ответственности FDA: Данные утверждения не были оценены Управлением по санитарному надзору за качеством пищевых продуктов и медикаментов (FDA). Продукты и информация на этом сайте не предназначены для диагностики, лечения, излечения или профилактики каких-либо заболеваний. Представленные оценки доказательности основаны на нашем анализе опубликованных рецензируемых исследований и не являются медицинской консультацией. Всегда консультируйтесь с лечащим врачом перед началом приёма любых добавок.